{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:21:31Z","timestamp":1778152891937,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Union Specific Project Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University","award":["202301AY070001-073"],"award-info":[{"award-number":["202301AY070001-073"]}]},{"name":"Comprehensive Prevention and Control of Chronic Obstructive Pulmonary Disease in Yunnan Province based on Population Medical Model\u201d of Chinese Academy of Engineering","award":["NO.2022-DFZD-30"],"award-info":[{"award-number":["NO.2022-DFZD-30"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-11874-4","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:09:16Z","timestamp":1732784956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors contributing to hospitalization expenditures for patients with COPD in Yunnan Province, China: a path analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Aihan","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geyi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"7","key":"11874_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","volume":"207","author":"Bartolom\u00e9R \u00c0lvar Agust\u00ed","year":"2023","unstructured":"\u00c0lvar Agust\u00ed Bartolom\u00e9R, Celli GJ, Criner, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 2023;207(7):819\u201337.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10131","key":"11874_CR2","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","volume":"391","author":"C Wang","year":"2018","unstructured":"Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706\u201317.","journal-title":"Lancet"},{"issue":"20","key":"11874_CR3","first-page":"3654","volume":"45","author":"Y Shan","year":"2018","unstructured":"Shan Y, Yang Y, Qin M, et al. Analysis of the prevalence and influencing factors of chronic obstructive pulmonary disease among residents aged 40 years and above in Yunnan Province. Mod Prev Med. 2018;45(20):3654\u20138.","journal-title":"Mod Prev Med"},{"issue":"9434","key":"11874_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(04)16855-4","volume":"364","author":"RA Pauwels","year":"2004","unstructured":"Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613\u201320.","journal-title":"Lancet"},{"issue":"1","key":"11874_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1440-1843.2011.02073.x","volume":"17","author":"WS Teo","year":"2012","unstructured":"Teo WS, Tan WS, Chong WF, et al. Economic burden of chronic obstructive pulmonary disease. Respirology. 2012;17(1):120\u20136.","journal-title":"Respirology"},{"issue":"4","key":"11874_CR6","first-page":"253","volume":"32","author":"Q He","year":"2009","unstructured":"He Q, Zhou X, Xie C, et al. Impact of chronic obstructive pulmonary disease on the quality of life and economic burden of patients in selected Chinese cities. Chin J Tuberculosis Respiratory Med. 2009;32(4):253\u20137.","journal-title":"Chin J Tuberculosis Respiratory Med"},{"key":"11874_CR7","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2147\/COPD.S118523","volume":"11","author":"X Chen","year":"2016","unstructured":"Chen X, Wang N, Chen Y, et al. Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities. Int J Chronic Obstr Pulm Dis. 2016;11:2625\u201332.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"17","key":"11874_CR8","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1001\/archinte.160.17.2653","volume":"160","author":"DW Mapel","year":"2000","unstructured":"Mapel DW, Hurley JS, Frost FJ, et al. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med. 2000;160(17):2653\u20138.","journal-title":"Arch Intern Med"},{"issue":"0","key":"11874_CR9","first-page":"2609","volume":"0","author":"D Amol","year":"2015","unstructured":"Amol D, Dhamane C, Moretz Y, Zhou, et al. COPD exacerbation frequency and its association with health care resource utilization and costs. Int J Chronic Obstr Pulm Dis. 2015;0(0):2609\u20132609.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"0","key":"11874_CR10","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.2147\/COPD.S175143","volume":"13","author":"M Li","year":"2018","unstructured":"Li M, Wang F, Chen R, et al. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data. Int J Chronic Obstr Pulm Dis. 2018;13(0):3349\u201357.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"4","key":"11874_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.rmed.2011.10.013","volume":"106","author":"J Petra Menn","year":"2012","unstructured":"Petra Menn J, Heinrich RM, Huber, et al. Direct medical costs of COPD \u2013 an excess cost approach based on two population-based studies. Respir Med. 2012;106(4):540\u20138.","journal-title":"Respir Med"},{"issue":"4","key":"11874_CR12","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.chest.2020.09.255","volume":"159","author":"Z Zafari","year":"2021","unstructured":"Zafari Z, Li S, Eakin MN, et al. Projecting Long-Term Health and Economic Burden of COPD in the United States. Chest. 2021;159(4):1400\u201310.","journal-title":"Chest"},{"key":"11874_CR13","doi-asserted-by":"publisher","unstructured":"Koul PA, Nowshehr AA, Khan UH, Jan RA, Shah SU. Cost of severe chronic obstructive pulmonary disease exacerbations in a high Burden Region in North India. Ann Glob Health. 2019;85(1):13. https:\/\/doi.org\/10.5334\/aogh.2423.","DOI":"10.5334\/aogh.2423"},{"issue":"5","key":"11874_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/bmjopen-2012-000869","volume":"2","author":"G Agboado","year":"2012","unstructured":"Agboado G, Peters J, Donkin L. Factors influencing the length of hospital stay among patients resident in Blackpool admitted with COPD: a cross-sectional study. Bmj Open. 2012;2(5):231\u20139.","journal-title":"Bmj Open"},{"issue":"07","key":"11874_CR15","first-page":"19","volume":"28","author":"J Huang","year":"2015","unstructured":"Huang J. Analysis of factors affecting the direct economic burden of patients hospitalized with chronic obstructive pulmonary disease in a tertiary hospital in Beijing. Med Soc. 2015;28(07):19\u201322.","journal-title":"Med Soc"},{"issue":"06","key":"11874_CR16","first-page":"514","volume":"27","author":"G Hua","year":"2021","unstructured":"Hua G, Fang H, Ming Q. Analysis of factors affecting hospitalization expenditures of 257134 patients with chronic obstructive pulmonary disease in Yunnan Province in 2019[J]. Appl Prev Med. 2021;27(06):514\u20136.","journal-title":"Appl Prev Med"},{"issue":"29","key":"11874_CR17","doi-asserted-by":"publisher","first-page":"e11491","DOI":"10.1097\/MD.0000000000011491","volume":"97","author":"H Rosarin Sruamsiri","year":"2018","unstructured":"Rosarin Sruamsiri H, Kubo J\u00f6rg. Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus. Medicine. 2018;97(29):e11491-11491.","journal-title":"Medicine"},{"issue":"06","key":"11874_CR18","first-page":"61","volume":"38","author":"W Ting","year":"2019","unstructured":"Ting W, Li Y, Qian L, et al. Analysis of factors affecting hospitalization costs for lung cancer surgery patients based on structural equation modeling. Chin Health Econ. 2019;38(06):61\u20133.","journal-title":"Chin Health Econ"},{"issue":"06","key":"11874_CR19","first-page":"87","volume":"24","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Yuan D, Yue L, et al. Analysis of factors influencing hospitalization costs of cirrhotic patients based on structural equation modeling. Chin Med Records. 2023;24(06):87\u201390.","journal-title":"Chin Med Records"},{"key":"11874_CR20","unstructured":"Notice of the Ministry of Health on the revision of the first page of the hospitalization cases. National Health Commission of the People\u2019s Republic of China. 2011. http:\/\/www.nhc.gov.cn\/wjw\/gfxwj\/201304\/47b4226ff93c4800bab61c045ddb6642.shtml. Accessed 16 Sep 2024."},{"key":"11874_CR21","doi-asserted-by":"publisher","first-page":"859499","DOI":"10.3389\/fpubh.2022.859499","volume":"10","author":"PWJ Yin","year":"2022","unstructured":"Yin PWJ, Wang L, et al. The Burden of COPD in China and its provinces: findings from the global burden of Disease Study 2019. Front Public Health. 2022;10:859499.","journal-title":"Front Public Health"},{"issue":"01","key":"11874_CR22","first-page":"55","volume":"30","author":"J Lin","year":"2023","unstructured":"Lin J. Analysis of patients\u2019 sub-average hospitalization costs in tertiary public hospitals based on the degree of structural change. China Hosp Stat. 2023;30(01):55\u20138.","journal-title":"China Hosp Stat"},{"issue":"02","key":"11874_CR23","first-page":"69","volume":"40","author":"X Huang","year":"2023","unstructured":"Huang X, Li Y, Yang Y. Study on the evaluation of cost control effect of relevant Medical Reform policies\u2013based on Zero Markup on drugs, Zero Markup on Consumables, and Value-based payment for medical cases. Health Econ Res. 2023;40(02):69\u201373.","journal-title":"Health Econ Res"},{"key":"11874_CR24","doi-asserted-by":"publisher","first-page":"618046","DOI":"10.3389\/fmed.2021.618046","volume":"8","author":"W Liu","year":"2021","unstructured":"Liu W, Hsu CH, Liu T, et al. Systematic review of the Effect of a zero-markup policy for essential drugs on Healthcare costs and utilization in China, 2015\u20132021. Front Med (Lausanne). 2021;8\u2013618046.","journal-title":"Front Med (Lausanne)"},{"key":"11874_CR25","volume-title":"Study on the influencing factors of medical costs of patients hospitalized with chronic obstructive pulmonary disease in a tertiary hospital in Guizhou Province","author":"J Liang","year":"2023","unstructured":"Liang J. Study on the influencing factors of medical costs of patients hospitalized with chronic obstructive pulmonary disease in a tertiary hospital in Guizhou Province. Guizhou University; 2023."},{"key":"11874_CR26","volume-title":"Research on the analysis of influencing factors of hospitalization cost of participating farmers based on recursive system model and structural equation model","author":"M Ren","year":"2012","unstructured":"Ren M. Research on the analysis of influencing factors of hospitalization cost of participating farmers based on recursive system model and structural equation model. Guangxi Medical University; 2012."},{"issue":"14","key":"11874_CR27","first-page":"1138","volume":"16","author":"H Shan","year":"2018","unstructured":"Shan H, Yu J, Han X, et al. Analysis of recursive system and structural equation modeling of factors influencing hospitalization costs for patients with chronic obstructive pulmonary disease[J]. J Community Med. 2018;16(14):1138\u201345.","journal-title":"J Community Med"},{"issue":"06","key":"11874_CR28","first-page":"61","volume":"38","author":"T Wang","year":"2019","unstructured":"Wang T, Yu L, Lang Q, et al. Analysis of factors affecting hospitalization costs of lung cancer surgery patients based on structural equation modeling. China Health Econ. 2019;38(06):61\u20133.","journal-title":"China Health Econ"},{"issue":"7","key":"11874_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1513\/pats.200603-094SS","volume":"3","author":"D Scott","year":"2006","unstructured":"Scott D, Ramsey, Richard Hobbs. Chronic obstructive Pulmonary Disease, Risk factors, and outcome trials: comparisons with Cardiovascular Disease. Annals Am Thorac Soc. 2006;3(7):635\u201340.","journal-title":"Annals Am Thorac Soc"},{"issue":"6","key":"11874_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/14737167.2020.1678385","volume":"20","author":"AU Rehman","year":"2019","unstructured":"Rehman AU, Hassali MA, Muhammad SA, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Rev PharmacoEcon Outcomes Res. 2019;20(6):661\u201372.","journal-title":"Expert Rev PharmacoEcon Outcomes Res"},{"key":"11874_CR31","doi-asserted-by":"crossref","unstructured":"Ruparel M, L\u00f3pez-Campos JL, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts CM. Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit. ERJ Open Res. 2016;2(1):00034-2015.","DOI":"10.1183\/23120541.00034-2015"},{"issue":"2","key":"11874_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10198-019-01119-1","volume":"21","author":"AU Rehman","year":"2020","unstructured":"Rehman AU, Hassali MAA, Muhammad SA, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. Eur J Health Econ. 2020;21(2):181\u201394.","journal-title":"Eur J Health Econ"},{"issue":"9","key":"11874_CR33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1164\/rccm.202012-4389OC","volume":"204","author":"MS Stefan","year":"2021","unstructured":"Stefan MS, Pekow PS, Priya A, et al. Association between Initiation of Pulmonary Rehabilitation and Rehospitalizations in patients hospitalized with chronic obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;204(9):1015\u201323.","journal-title":"Am J Respir Crit Care Med"},{"key":"11874_CR34","doi-asserted-by":"crossref","unstructured":"Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164.","DOI":"10.1183\/13993003.00164-2019"},{"issue":"1","key":"11874_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12877-023-04087-7","volume":"23","author":"C Yu","year":"2023","unstructured":"Yu C, Xia Q, Li Q, et al. Hospitalization costs of COPD cases and its associated factors: an observational study at two large public tertiary hospitals in Henan Province, China. BMC Geriatr. 2023;23(1):457.","journal-title":"BMC Geriatr"},{"issue":"05","key":"11874_CR36","first-page":"1196","volume":"36","author":"H Zhao","year":"2016","unstructured":"Zhao H, Bai Y, Li M, et al. Hospitalization status and direct economic burden of chronic obstructive pulmonary disease in the elderly. Chin J Gerontol. 2016;36(05):1196\u20138.","journal-title":"Chin J Gerontol"},{"key":"11874_CR37","doi-asserted-by":"publisher","unstructured":"Jianping R, Hua L, Zhengzhong M, Zhengmin Y, Zhicheng D, Yurun Z, et al. Study on the economic burden of chronic obstructive pulmonary disease and its influencing factors. Health Econ Res. 2002(10):16\u20137. https:\/\/doi.org\/10.14055\/j.cnki.33-1056\/f.2002.10.005.","DOI":"10.14055\/j.cnki.33-1056\/f.2002.10.005"},{"issue":"06","key":"11874_CR38","first-page":"559","volume":"20","author":"H Wang","year":"2020","unstructured":"Wang H, Zeng Y, Lian G, et al. Survey on the Impact of Family Support on Quality of Life and Medical Assistance for the Elderly. J Nanjing Med Univ (Social Sci Edition). 2020;20(06):559\u201363.","journal-title":"J Nanjing Med Univ (Social Sci Edition)"},{"issue":"04","key":"11874_CR39","first-page":"740","volume":"43","author":"Q Feng","year":"2023","unstructured":"Feng Q, Yan C. Analysis of factors affecting hospitalization costs of patients with chronic obstructive pulmonary disease in Hunan Province. J Hunan Univ Traditional Chin Med. 2023;43(04):740\u20136.","journal-title":"J Hunan Univ Traditional Chin Med"},{"issue":"3","key":"11874_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.36497\/respirsci.v1i3.21","volume":"1","author":"Agus Kosasih","year":"2021","unstructured":"Agus Kosasih. Implementation of clinical pathway for management of Copd Exacerbation. Respiratory Sci. 2021;1(3):166\u201373.","journal-title":"Respiratory Sci"},{"issue":"1","key":"11874_CR41","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1186\/1471-2466-12-27","volume":"12","author":"A B\u00e1n","year":"2012","unstructured":"B\u00e1n A, Aniza Ismail R, Harun, et al. Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation. BMC Pulm Med. 2012;12(1):0\u20130.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"11874_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000510615","volume":"100","author":"Y Yu","year":"2021","unstructured":"Yu Y, Liu W, Jiang HL, et al. Pneumonia is Associated with increased mortality in hospitalized COPD patients: a systematic review and Meta-analysis. Respiration. 2021;100(1):64\u201376.","journal-title":"Respiration"},{"issue":"0","key":"11874_CR43","first-page":"341","volume":"0","author":"A Anand","year":"2010","unstructured":"Anand A, Dalal L, Christensen F, Liu, et al. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chronic Obstr Pulm Dis. 2010;0(0):341\u2013341.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"11874_CR44","unstructured":"Terzano C, Colamesta V, Unim B, Romani S, Meneghini A, Volpe G, et al. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization. Eur Rev Med Pharmacol Sci. 2017;21(16):3680\u20139."},{"issue":"04","key":"11874_CR45","first-page":"605","volume":"49","author":"L Jia","year":"2022","unstructured":"Jia L, Gui L, Juan H, et al. Passage analysis of factors affecting hospitalization expenditures in patients with chronic obstructive pulmonary disease. Mod Prev Med. 2022;49(04):605\u20138.","journal-title":"Mod Prev Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11874-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-11874-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11874-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T10:30:30Z","timestamp":1732789830000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-11874-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11874"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-11874-4","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was initiated and led by the First People\u2019s Hospital of Yunnan Province and was approved by the Ethics Committee of the First People\u2019s Hospital of Yunnan Province (KHLL2022-KY141-C-1). Written informed consent has been obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1496"}}